Broadreach Global

Meet some of the Leading Investors speaking at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience Sourav Kole Dolby Family Ventures Stacie Weninger F-Prime Capital Claire Leurent PhD MBA AbbVie Thomas Michael Thestrup Angelini Ventures Steven Biesmans UCB Ventures Raúl Martín-Ruiz Ysios Capital Philip Scheltens EQT Life Sciences Clara Campàs Moya Asabys Partners Hakan Goker M Ventures

Meet some of the CEO’s and C-Level Speakers at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience

Meet leading Industry decision-makers speaking at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience Pablo Sardi Sanofi Tarek Samad Lundbeck Jan Klatt Merck KGaA, Darmstadt, Germany Hugh Nuthall Eli Lilly and Company Nawal Roy Holmusk Jacopo Andreose Angelini Pharma Joachim Scholpp Boehringer Ingelheim Beckman Coulter Life Sciences Julius Clinical Catalent Pharma Solutions

REGISTER NOW - JUST 5 DAYS LEFT FOR EARLY REGISTRATION IF YOU ARE A SERIOUS STAKEHOLDER IN CNS NEUROSCIENCE DRUG DEVELOPMENT, THIS IS THE KEY INVESTMENT & PARTNERING MEETING OF THE YEAR. https://lnkd.in/eJcBGZ2t

Meet the Keynote Speakers at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience

ONE WEEK LEFT to secure your spot at the global summit of 200 of the leading CNS Neuroscience drug development pioneers, CEOs, investors and executives. Don’t miss the chance to save up to €400, and be part of Bio-Neuroscience 2025. REGISTER by 30 November 2024: https://lnkd.in/eJcBGZ2t

Just 10 Days left to secure your spot at the global summit of 200 of the leading CNS Neuroscience drug development pioneers, CEOs, investors and executives. Don’t miss the chance to save up to €400, and be part of Bio-Neuroscience 2025. REGISTER by 30 November 2024: https://lnkd.in/eJcBGZ2t

Broadreach Global was honored to once again work with the fantastic healthcare team at FTI Consulting and with EUCOPE - European Confederation of Pharmaceutical Entrepreneurs on the report "The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments." Please have a look to understand the investor perspective on improving access to innovative medicines in Europe while fostering rather than stifling innovation and the European biotechnology sector, in light of the proposed EU Pharmaceutical Package. SEE THE REPORT https://lnkd.in/e_SSs2H7 It was a pleasure working with Katja Murray, Victor Maertens, Stefano Romanelli, Tiago Beck, and Lars Stollenwerk, and of course with leading EU biotech investors from the Broadreach Global network, including Cedric Bisson of Teralys Capital, Bruno Montanari of Seroba., Raúl Martín-Ruiz of Ysios Capital, Manuel Lopez-Figueroa of Bay City Capital LLC, as well as top funds which contributed anonymously, angel investors Mark Treherne and Till Erdmann, and Andrea Soto Padilla. Special thanks to Antoine Mialhe and Alexander Natz

I was honored that Broadreach Global was once again able to support the European Brain Council's Brain Innovation Days annual meeting in Brussels as an official partner. Thanks to Kristien AARTS, Stephanie Kramer, Hugo Hermantin Dieyenaba Faye and everyone on the EBC and BID teams that helped make this unique European event a success. It was a privilege to organize and moderate a panel discussion, this time on innovation and finding synergies in the various EC policies impacting brain health innovation. Thanks to our wonderful speakers Patricia Gall at MindSpark 360 , Raúl Martín-Ruiz at Ysios Capital and of course Frédéric Destrebecq of the EBC. And thanks Patricia for getting ahold of this great snapshot of our session!

Only 20 days left to secure Early Registration and submit your application to present! Don’t miss the chance to save up to €400, and be part of Bio-Neuroscience 2025. REGISTER by 30 November 2024: https://lnkd.in/eJcBGZ2t